Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atezolizumab and Bevacizumab in Hepatocellular Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04224636
What this trial is testing

Atezolizumab/Bevacizumab Followed by On-demand TACE or Initial Synchronous Treatment With TACE and Atezolizumab/Bevacizumab

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Ludwig-Maximilians - University of Munich 106
Not applicableStudy completedNCT05197504
What this trial is testing

Predictive Biomarkers in Patients With Advanced Hepatocellular Carcinoma Treated With Systemic Therapy

Who this might be right for
Hepatocellular Carcinoma
CHA University 166
Testing effectiveness (Phase 2)Looking for participantsNCT05168163
What this trial is testing

Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer

Who this might be right for
Locally Advanced Hepatocellular CarcinomaMetastatic Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC v8+6 more
Academic and Community Cancer Research United 122
Not applicableStudy completedNCT07109336
What this trial is testing

Development and Prospective Validation of a Heterogeneous Treatment Effect-Based Decision Model for Transarterial Chemoembolization Combined With or Without Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma

Who this might be right for
HCC - Hepatocellular Carcinoma
Zhongda Hospital 236
Not applicableStudy completedNCT07272265
What this trial is testing

The Effectiveness and Safety in High-risk Patients Receiving First-line Atezolizumab and Bevacizumab Combined With HAIC for HCC: a Retrospective Study

Who this might be right for
Hepatocellular Carcinoma (HCC)
Sun Yat-sen University 300
Not applicableNot Yet RecruitingNCT07543510
What this trial is testing

Low-Dose Bevacizumab and Atezolizumab Combined With TACE-HAIC in Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaAtezolizumab Plus BevacizumabTransarterial Chemoembolization
Third Affiliated Hospital, Sun Yat-Sen University 38
Not applicableLooking for participantsNCT06961526
What this trial is testing

Esophageal Varices Prophylaxis in Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab

Who this might be right for
Esophageal and/or Gastric VaricesHepatocellular Carcinoma (HCC)
Tanta University 110
Not applicableEnrolling By InvitationNCT07088081
What this trial is testing

Evaluation of Efficacy and Safety of Immune Check Point Inhibitors in Hepatocellular Carcinoma Patients in Ain Shams University Hospitals

Who this might be right for
HCC - Hepatocellular CarcinomaImmunotherapyImmune Checkpoint Therapy+3 more
Ain Shams University 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04563338
What this trial is testing

An Exploratory Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma and Non-Small Cell Lung Cancer With Liver Metastases (INTEGRATE)

Who this might be right for
Hepatocellular CarcinomaNon-small Cell Lung Cancer MetastaticLiver Metastases
University Health Network, Toronto 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT06096779
What this trial is testing

A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 Cirrhosis

Who this might be right for
Hepatocellular Carcinoma
Genentech, Inc. 30
Not applicableLooking for participantsNCT07610551
What this trial is testing

Efficacy and Safety of SIRT-Y90 in Combination With Atezo + Bev for Unresectable Hepatocellular Carcinoma

Who this might be right for
HCC - Hepatocellular Carcinoma
Air Force Military Medical University, China 50
Not applicableUnknownNCT06024252
What this trial is testing

Efficacy, Safety, and Treatment Patterns of Transcatheter Arterial Chemoembolization (TACE) Combined With Atezolizumab and Bevacizumab in Unresectable Hepatocellular Carcinoma: a Multicenter, Retrospective, Observational Real-world Study

Who this might be right for
HCC
Zhongda Hospital 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT05211323
What this trial is testing

Determine Whether Chemotherapy and Atezolizumab is Better Than Chemotherapy, Bevacizumab and Atezolizumab in Patients With Advanced Liver Cancer

Who this might be right for
Combined Hepatocellular Carcinoma and CholangiocarcinomaStage III Liver CancerStage IV Liver Cancer
National Cancer Institute (NCI) 4
Testing effectiveness (Phase 2)Active Not RecruitingNCT06138769
What this trial is testing

Lenvatinib After Progression on Atezolizumab-bevacizumab in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Asan Medical Center 50
Testing effectiveness (Phase 2)Looking for participantsNCT05516628
What this trial is testing

Deep, Multi-omics Phenotyping to Predict Response, Resistance and Recurrence to Adjuvant Atezolizumab Plus Bevacizumab in Resected Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
National Cancer Centre, Singapore 30
Testing effectiveness (Phase 2)Looking for participantsNCT05468359
What this trial is testing

Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients

Who this might be right for
Refractory Solid TumorHepatocellular CarcinomaMalignant Solid Tumor+3 more
St. Jude Children's Research Hospital 64
Not applicableStudy completedNCT07193316
What this trial is testing

Safety and Efficacy of Atezolizumab-Bevacizumab Versus Tyrosin Kinase Inhibitors in Patients With Liver Cirrhosis

Who this might be right for
Hepatocellular CarcinomaLiver Cirrhosis
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 38
Large-scale testing (Phase 3)Active Not RecruitingNCT04770896
What this trial is testing

Atezolizumab With Lenvatinib or Sorafenib Versus Lenvatinib or Sorafenib Alone in Hepatocellular Carcinoma Previously Treated With Atezolizumab and Bevacizumab

Who this might be right for
Unresectable Hepatocellular Carcinoma
Hoffmann-La Roche 557
Testing effectiveness (Phase 2)Looking for participantsNCT06695026
What this trial is testing

Evaluate the Safety, Tolerability and Efficacy of RZ-001 in Combination With Valganciclovir (VGCV) and Atezolizumab/Bevacizumab in Subjects With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Rznomics, Inc. 45
Not applicableNot Yet RecruitingNCT06903663
What this trial is testing

The Epidemiology of Patients Treated With ATZ+BEV in Real Life Setting

Who this might be right for
Hepatocellular Carcinoma (HCC)
Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian Fodor 100
Next Page